US Bancorp’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $493K | Sell |
|
|||||
|
2025
Q2 | $516K | Buy |
|
|||||
|
2025
Q1 | $412K | Sell |
|
|||||
|
2024
Q4 | $570K | Buy |
|
|||||
|
2024
Q3 | $445K | Sell |
|
|||||
|
2024
Q2 | $767K | Buy |
|
|||||
|
2024
Q1 | $684K | Sell |
|
|||||
|
2023
Q4 | $775K | Buy |
|
|||||
|
2023
Q3 | $603K | Sell |
|
|||||
|
2023
Q2 | $1.03M | Sell |
|
|||||
|
2023
Q1 | $2.39M | Buy |
|
|||||
|
2022
Q4 | $2.74M | Sell |
|
|||||
|
2022
Q3 | $3.1M | Sell |
|
|||||
|
2022
Q2 | $3.04M | Buy |
|
|||||
|
2022
Q1 | $2.92M | Buy |
|
|||||
|
2021
Q4 | $1.84M | Sell |
|
|||||
|
2021
Q3 | $2.92M | Sell |
|
|||||
|
2021
Q2 | $3M | Buy |
|
|||||
|
2021
Q1 | $2.83M | Buy |
|
|||||
|
2020
Q4 | $2.08M | Buy |
|
|||||
|
2020
Q3 | $1.75M | Buy |
|
|||||
|
2020
Q2 | $546K | Buy |
|
|||||
|
2020
Q1 | $330K | Buy |
|
|||||
|
2019
Q4 | $410K | Buy |
|
|||||
|
2019
Q3 | $281K | Buy |
|
|||||
|
2019
Q2 | $244K | Sell |
|
|||||
|
2019
Q1 | $254K | Buy |
|
|||||
|
2018
Q4 | $91K | Buy |
|
|||||
|
2018
Q3 | $99K | Buy |
|
|||||
|
2018
Q2 | $75K | Buy |
|
|||||
|
2018
Q1 | $59K | Buy |
|
|||||
|
2017
Q4 | $31K | Sell |
|
|||||
|
2017
Q3 | $57K | Buy |
|
|||||
|
2017
Q2 | $28K | Buy |
|
|||||
|
2017
Q1 | $12K | Sell |
|
|||||
|
2016
Q4 | $18K | Buy |
|
|||||
|
2016
Q3 | $1K | Sell |
|
|||||
|
2016
Q2 | $24K | Sell |
|
|||||
|
2016
Q1 | $39K | Sell |
|
|||||
|
2015
Q4 | $145K | Buy |
|
|||||
|
2015
Q3 | $45K | Sell |
|
|||||
|
2015
Q2 | $68K | Buy |
|
|||||
|
2015
Q1 | $54K | Buy |
|
|||||
|
2014
Q4 | $4K | Hold |
|
|||||
|
2014
Q3 | $3K | Hold |
|
|||||
|
2014
Q2 | $3K | Hold |
|
|||||
|
2014
Q1 | $3K | Hold |
|
|||||
|
2013
Q4 | $2K | Hold |
|
|||||
|
2013
Q3 | $2K | Hold |
|
|||||
|
2013
Q2 | $3K | Buy |
|